¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"inflammatory polyp"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® polyp ÇÑ±Û Æú¸³
¼³¸í   
  Á¡¸·¿¡ ¹ß»ýÇϴ ¹ö¼¸ ¸ð¾çÀÇ Á¾¾çÀ» À̸£´Â ¿ë¾î. ±× »ý±ä ¸ð¾ç¿¡ ±× »ý±ä ¸ð¾ç¿¡ µû¶ó ºÎ¸¦ »ÓÀ̸ç, ½ÇÁ¦ÀûÀ¸·Î Çö¹Ì°æÀû ¸ð¾çÀ̳ª ±¸¼º¼¼Æ÷´Â °¢±â ´Ù¸£´Ù. ´ëÇ¥ÀûÀΠ¿¹¸¦ µé¸é, Àß·èâÀÚ Æú¸³À» µé ¼ö ÀÖ´Ù. Å«Ã¢ÀÚ Á¡¸·¿¡ »ý±ä Æú¸³À¸·Î ³»°­ ÂÊÀ¸·Î µ¹ÃâµÈ º´º¯À» ¸ðµÎ Æ÷ÇÔÇϸç, Å©°Ô Áõ½ÄÆú¸³°ú »ùÁ¾ Æú¸³À¸·Î ±¸ºÐµÈ´Ù. »ùÁ¾¼ºÀº Áø¼ºÁ¾¾çÀ̰í, ¶§·Î´Â ÀÛÀº ¾ÏÁ¾À» Æ÷ÇÔÇϱ⵵ Çϸç, Áõ½Ä¼ºÀº ¾ç¼º º´º¯À¸·Î Á¶ÀýÀÌ µÇ¾î Àִ °ú´Ù Áõ½ÄÀ¸·Î °£ÁÖÇϰí ÀÖ´Ù.
¿µ¹® pelvic inflammatory disease ÇÑ±Û °ñ¹Ý¿°Áúȯ
¼³¸í   
  °ñ¹ÝÁÖÀ§ÀÇ Àå±â¿¡ ¹ß»ýÇϴ ¿°ÁõÀ» ¸»ÇÔ. ÁַΠ¿©¼º¿¡¼­ ¹ß»ýÇϸ砿øÀÎÀº ÀÓ±Õ(gonococcus)°ú ºñÀÓ±Õ¿¡ ÀÇÇÑ °¨¿°(non-gonorrheal infection)¿¡ ÀÇÇÑ´Ù. Áõ»óÀº Ãʱ⿡´Â ÁúºÐºñ¹°, ÇϺ¹ºÎµ¿Åë, ¿©¼ºÀÇ »ý½Ä±âºÎÀ§¿¡ ¹ß»ýÇϴ ¾ÐÅë, ¿ù°æÅë, ¿ù°æ·®ÀÇ Áõ°¡ µîÀÌ´Ù. ÀÏÂï Ä¡·áÇØ¾ß Çϸç, °è¼ÓÀûÀ¸·Î º´ÀÌ Áö¼Ó½Ã ¿©¼ºÀÇ ºÒÀÓÀÇ ¿øÀÎÀÌ µÈ´Ù. ÈÄÁø±¹¿¡¼­´Â °¡Àå ¸¹Àº ¿©¼ººÒÀÓÀÇ ¿øÀÎÀ̱⵵ ÇÔ. Ä¡·á´Â Ç×»ýÁ¦ÀÇ Åõ¿©ÀÌ´Ù.
¿µ¹® inflammatory bowel disease ÇÑ±Û ¿°Áõ¼ºÃ¢ÀÚº´
¼³¸í   
  À§Àå°üÀ» Ä§¹üÇϴ Á¤È®ÇÑ ¿øÀÎÀÌ ¹àÇôÁöÁö ¾ÊÀº ¸¸¼ºÀûÀΠ¿°Áõ¼º ÁúȯÀ» ¸»ÇÑ´Ù. Å©°Ô ¡®±Ë¾ç¼º ´ëÀå¿°¡¯(ulcerative colitis)°ú ¡®Å©·Ðº´¡¯(Crohn's disease)ÀÇ µÎ Á¾·ù·Î ±¸ºÐµÈ´Ù. ¹éÀÎ, À¯ÅÂÀο¡ ¸¹°í ÈæÀÎÀ̳ª µ¿¾çÀο¡´Â µå¹°Áö¸¸ µ¿¾çÀο¡¼­ Á¡Â÷ Áõ°¡Ãß¼¼¿¡ ÀÖ´Ù. È£¹ß¿¬·ÉÀº 15~35¼¼ »çÀÌÀÌ´Ù. Áõ»óÀº ¡®±Ë¾ç¼º ´ëÀå¿°¡¯ÀÇ °æ¿ì, ¼³»ç(Ç÷º¯ ¹× Á¡¾×º¯), µÚ¹«Á÷, º¹Åë, º¹ºÎ¾ÐÅë, Ã¼Áß°¨¼Ò µîÀÌ ÁַΠ³ªÅ¸³ª¸ç ¡®Å©·Ðº´¡¯¿¡¼­´Â ¼³»ç¿Í Ã¼Áß°¨¼Ò, ¿ìÇϺ¹ºÎ Á¾·ù, Ç×¹®ÁÖÀ§ ÀÌ»ó, º¹ºÎ¾ÐÅë µîÀÌ ³ªÅ¸³­´Ù. Áø´ÜÀº º´·Â°ú ¹æ»ç¼±ÇÐÀû °Ë»ç, Á÷Àå°æ ¹× ´ëÀå ³»½Ã°æ°Ë»ç, Á÷Àå ¹× ´ëÀåÀÇ Á¶Á÷°Ë»ç·Î Çϸç Ä¡·á´Â ³»°úÀûÀΠġ·á°¡ ¿øÄ¢À̳ª ³»°úÀû Ä¡·á¿¡ µèÁö ¾Ê°Å³ª ÇÕº´ÁõÀÌ »ý±æ °æ¿ì¿¡´Â ¿Ü°úÀû Ä¡·á¸¦ ½ÃÇàÇÑ´Ù. ¡®±Ë¾ç¼º ´ëÀå¿°¡¯ÀÇ °æ¿ì¿¡´Â ¡®´ëÀå¾Ï¡¯À» ¿¹¹æÇϱâ À§Çؼ­ ¿Ü°úÀû Ä¡·á¸¦ Çϱ⵵ ÇÑ´Ù. ¡®±Ë¾ç¼º ´ëÀå¿°¡¯°ú ¡®Å©·Ð º´¡¯¿Ü¿¡ ¿°Áõ¼º Ã¢ÀÚº´¿¡ ¼ÓÇϴ ¡®º£Ã¼Æ® º´¡¯Àº Àç¹ß¼º ±¸°­³» ±Ë¾ç, ÇǺΠº´º¯, ¾È±¸ºÎ ¿°Áõ, ¿ÜÀ½ºÎ ±Ë¾ç, °üÀý¿° Áõ»ó, À§Ã¢ÀÚ°ü Áõ»ó(º¹Åë, ÀåÃâÇ÷), ºÎ°íȯ¿° µîÀÇ Áõ»óÀ» ³ªÅ¸³»´Âµ¥ Áø´Ü°ú Ä¡·á´Â ¡®±Ë¾ç¼º ´ëÀå¿°¡¯, ¡®Å©·Ð º´¡¯°ú ºñ½ÁÇÏ´Ù.
¿µ¹® anti-inflammatory agent ÇÑ±Û Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
¼³¸í   
  ±¹¼Ò¿¡ ÀÛ¿ëÇÏ¿© ¿°ÁõÀ» Ä¡·áÇÏ°í ¹æÁöÇϴ ¾à. ¿°ÁõÀ» °¡¶ó¾ÉÈ÷´Â ¾àÀ» ¸»ÇÑ´Ù. Á¶Á÷À» ±äÃà-Ä¡¹ÐÇϰԠÇÏ¿© Àå¾×°ú Á¡¾×ÀÇ ºÐºñ¸¦ ÁÙÀ̰í, Ç¥¸é¿¡ Àִ ÀÛÀº Ç÷°ü¿¡ ºóÇ÷À» ÀÏÀ¸ÄÑ ÃæÇ÷µÇ´Â °ÍÀ» ¹æÁöÇÔÀ¸·Î½á ¿°ÁõÀû º´º¯À» Á¦°ÅÇÏ¿© ¸ðµç Áõ¼¼¸¦ ¾ø¾Ø´Ù. ´ëºÎºÐÀÇ ¼ö·ÅÁ¦-¿ÏÈ­Á¦-Áø¾çÁ¦°¡ ÀÌ¿¡ ¼ÓÇÑ´Ù. Áß¿äÇÑ ¼ººÐÀ¸·Î´Â ¾Ë·ç¹Ì´½-ºñ½º¹«Æ®-¾Æ¿¬-³³È­ÇÕ¹°(º´¹Ý-Æä¸£¸¶Åç-¾Æ¿¬È­-¿¬´ç µî) µîÀÌ ÀÖ´Ù. ÀÛ¿ë¿¡ µû¶ó Ç׿°ÁõÁøÅëÁ¦¿Í Ç׿°ÁõÈ¿¼ÒÁ¦·Î ³ª´¶´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inflammatory
    ¿°Áõ-
  • inflammatory bowel disease
    ¿°ÁõâÀÚÁúȯ, ¿°Áõ¼ºÀåÁúȯ
  • inflammatory carcinoma
    ¿°ÁõÇü¾ÏÁ¾
  • inflammatory cell
    ¿°Áõ¼¼Æ÷
  • inflammatory diarrhea
    ¿°Áõ¼³»ç
  • inflammatory fracture
    ¿°Áõ°ñÀý
  • inflammatory gangrene
    ¿°Áõ±«Àú
  • inflammatory lesion
    ¿°Áõº´ÅÍ, ¿°ÁõȯºÎ
  • inflammatory mediator
    ¿°Áõ¸Å°³Ã¼, ¿°Áõ¸Å°³¹°
  • inflammatory pseudotumor
    ¿°Áõ°ÅÁþÁ¾¾ç
  • inflammatory response
    ¿°Áõ¹ÝÀÀ
  • pelvic inflammatory disease
    °ñ¹Ý¿°ÁõÁúȯ, °ñ¹Ý¿°
  • systemic inflammatory response syndrome
    Àü½Å¿°Áõ¹ÝÀÀÁõÈıº
  • adenomatous polyp
    »ùÁ¾Æú¸³
  • cystic polyp
    ³¶¼ºÆú¸³
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyp
    Æú¸³, »ì¹ö¼¸
  • adenomatous polyp
    »ùÁ¾Æú¸³
  • endometrial polyp
    Àڱ󻸷Æú¸³, Àڱ󻸷»ì¹ö¼¸
  • gallbladder polyp
    ¾µ°³Æú¸³, ´ã³¶Æú¸³
  • juvenile polyp
    ¼Ò¾ÆÆú¸³
  • pedunculated polyp
    ÀÚ·ç-, ÁÙ±â-
  • anti-inflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • inflammatory cell
    ¿°Áõ¼¼Æ÷
  • inflammatory breast cancer
    ¿°ÁõÀ¯¹æ¾Ï
  • inflammatory bowel disease
    ¿°ÁõâÀÚÁúȯ
  • pelvic inflammatory disease
    °ñ¹Ý³»°¨¿°
  • inflammatory endometrium
    ¿°ÁõÀڱ󻸷, ¿°ÁõÀڱüӸ·
  • inflammatory
    ¿°Áõ-
  • inflammatory mediator
    ¿°Áõ¸Å°³Ã¼
  • inflammatory response
    ¿°Áõ¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • granulation polyp
    À°¾Æ¿ëÁ¾, À°¾Æ»ì¹ö¼¸
  • hydatid polyp
    Æ÷»óÆú¸³, Æ÷Ãæ³¶Æú¸³
  • lipomatous polyp
    Áö¹æÁ¾¼ºÆú¸³
  • nasal polyp
    ÄÚÆú¸³
  • polyp
    Æú¸³, »ì¹ö¼¸
  • periodontal polyp
    ÀÕ¸öÆú¸³, Ä¡ÁÖ¸·Æú¸³
  • anti-inflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • cervical inflammatory ectropion
    ¿°ÁõÀڱøñ¿Ü¹øÁõ, ¿°Áõ°æ°ü¿Ü¹øÁõ
  • inflammatory carcinoma
    ¿°Áõ¾ÏÁ¾
  • inflammatory cell
    ¿°Áõ¼¼Æ÷
  • inflammatory diarrhea
    ¿°Áõ¼³»ç
  • inflammatory bowel disease
    ¿°ÁõâÀÚº´, ¿°ÁõÀ庴
  • pelvic inflammatory disease
    °ñ¹Ý³»°¨¿°
  • inflammatory erythema
    ¿°ÁõÈ«¹Ý
  • inflammatory fracture
    ¿°Áõ°ñÀý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Inflammatory response
    ¿°Áõ¹ÝÀÀ(æúñøÚãëë)
  • acute inflammatory demyeliniating
    ±Þ¼º¿°Áõ¼ºÅ»¼öÃʼº(¡­æúñøàõ ÷­âÐÃÊàõ)
  • anti-inflammatory
    Ç׿°Áõ¼º(ù÷æúñøàõ)ÀÇ.
  • anti-inflammatory
    Ç׿°(Áõ)¼º
  • anti-inflammatory agent
    Ç׿°Áõ¾à(ù÷æúñøå·).
  • antral polyp
    »ó¾Çµ¿ Æú¸³
  • antrochoanal polyp
    »ó¾Çµ¿(¼º) Èĺñ°­ Æú¸³
  • gastric polyp
    À§Æú¸³, À§¿ëÁ¾
  • granulation polyp
    À°¾ÆÆú¸³
  • pharyngeal polyp
    ÀÎµÎÆú¸³, Àεοë
  • pharyngeal polyp
    ÀÎµÎÆú¸³(ìÖÔé¡­)
  • placental polyp
    ÅÂ¹ÝÆú¸³, ŹݿëÁ¾.
  • placental polyp
    ŹÝ(÷ÃÚï)Æú¸³
  • polyp
    ¿ëÁ¾
  • polyp
    Æú¸³, ¿ëÁ¾(éÇðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute inflammatory demyeliniating
    ±Þ¼º¿°Áõ¼ºÅ»¼öÃʼº(¡­æúñøàõ ÷­âÐÃÊàõ)
  • anti-inflammatory
    Ç׿°Áõ¼º(ù÷æúñøàõ)ÀÇ.
  • anti-inflammatory
    Ç׿°(Áõ)¼º
  • anti-inflammatory agent
    Ç׿°Áõ¾à(ù÷æúñøå·).
  • cell, inflammatory
    ¿°Áõ¼¼Æ÷
  • cervical inflammatory ectropium
    ¿°Áõ¼º °æ°üÁ¡¸·¿Ü¹ÝÁõ(æúñøàõÌòηïÄØ¯èâÚãñø).
  • chronic inflammatory demyelinating polyradiculoneuropathy
    ¸¸¼º¿°Áõ¼ºÅ»¼öÃʴٹ߼º½Å°æº´Áõ(¡­æúñúàõ÷­âÐÃÊÒýÛ¡àõãêÌèÜ»ñø)
  • edema,inflammatory
    ¿°Áõ¼º(æúñøàõ)
  • inflammatory bowel disease
    ¿°Áõ¼º ÀåÁúȯ
  • inflammatory bowel disease
    ¿°Áõ¼º ÀåÁúȯ(¡­ íóòðü´)
  • inflammatory carcinoma
    ¿°Áõ¼º ¾ÏÁ¾(¡­ äßðþ)
  • inflammatory diarrhea
    ¿°Áõ¼º ¼³»ç.
  • inflammatory erythema
    ¿°Áõ¼º È«¹Ý
  • inflammatory fracture
    ¿°Áõ¼º °ñÀý(æúñøàõÍéï¹).
  • inflammatory linear verrucous epidermal nevus (ILVEN)
    ¿°Áõ¼º ¼±»ó »ç¸¶±Í¾ç Ç¥ÇǸð¹Ý
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-inflammatory
    Ç׿°Áõ¾à, Ç׿°Áõ¼ºÀÇ
  • inflammatory
    ¿°Áõ¼º
  • inflammatory tissue
    ¿°ÁõÁ¶Á÷
  • pelvic inflammatory disease
    °ñ¹Ý¿°Áúȯ
  • adenomatous polyp
    ¼±Á¾¼º¿ëÁ¾
  • antral polyp
    »ó¾Çµ¿Æú¸³
  • cervical polyp
    °æ°üÆú¸³
  • choanal polyp
    Èĺñ°øÆú¸³
  • endometrial polyp
    Àڱ󻸷Æú¸³
  • fibrous polyp
    ¼¶À¯¼ºÆú¸³
  • gastric polyp
    À§Æú¸³
  • intestinal polyp
    ÀåÆú¸³
  • malignant polyp
    ¾Ç¼ºÆú¸³
  • mucous polyp
    Á¡¾×¼ºÆú¸³
  • multiple polyp
    ´Ù¹ß¼ºÆú¸³
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ICP incubation period; indwelling catheter program; infantile cerebral palsy; infection-control practiti...
IFP inflammatory fibroid polyp; insulin, compound F [hydrocortisone], prolactin; intermediate filament p...
PAIN pyoderma gangrenosum, aphthous stomatitis, inflammatory eye disease, erythema nodosum [disorders ass...
FGP fundic gland polyp
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IFP Inflammatory fibroid polyp
NP Nasal polyp
polyP Polyphosphate
AIDP Acute inflammatory demyelinating polyneuropathy
AIF-1 Allograft Inflammatory Factor-1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adenomatous polyp
    ¼±¾ç Æú¸³
    °áÀåÀÇ S »óºÎ·ÎºÎÅÍ Á÷Àå¿¡ °ÉÃļ­ È£¹ßÇÏ´Â Á¡¸·ÀÇ À¯µÎ»ó Áõ½ÄÀ¸·Î Á¤»ó Á¡¸·°ú µ¿ÀÏÇÑ ¼±°ü ±¸Á¶¸¦ ¸¸µé°í ÀÖ´Ù. ±×·¯³ª ¶§·Î´Â ¾Ç¼ºÀ¸·Î ÁøÀüµÇ´Â ÀÏÀÌ ÀÖ´Ù. ¼¼Æ÷ÁúÀº ¿°±â¼ºÀÌ °­Çϰí ÇÙÀº Å©·Î¸¶Æ¾ÀÌ Ç³ºÎÇÏ°í ½ÉºÎ·Î Áõ½ÄÇÏ´Â °æ¿ìµµ ÀÖ´Ù.
  • antronasal polyp
    »ó¾Çµ¿¼º ºñ°­ Æú¸³
  • bleeding polyp
    ÃâÇ÷¼º Æú¸³
  • cervical polyp
    °æ°ü Æú¸³
  • cherryred polyp
    ¼±È«»ö Æú¸³
  • cystic polyp
    ³¶¼º Æú¸³
  • endocervical polyp
    ÀÚ±Ã°æ ³»¸· ¿ëÁ¾
    ºñ±³Àû ÈçÇÏ¸ç ¿°Áõ¼º ºñ½Å»ý¹°¼º Á¾¾çÀ¸·Î 40-50´ë ¿©¼ºÀÇ 2-5%¿¡¼­ ¹ß»ýÇÑ´Ù. ÀÓ»óÀû ÀÇÀÇ´Â ºÒ±ÔÄ¢ÇÑ ÁúÀÇ Á¡»ó ÃâÇ÷ ¶Ç´Â Áú ÃâÇ÷·Î ÀÎÇØ ¾Ç¼º º´º¯À» ÀǽÉÄÉ ÇÏ´Â °ÍÀÌ´Ù. ¿ëÁ¾ÀÇ ´ëºÎºÐÀº ÇÑ °³À̸ç ÁÖ·Î ÀÚ±Ã°æ ³»¸·°ü ¾È¿¡¼­ »ý±â°í Å©±â´Â ´Ù¾çÇϸç Á÷°æÀº ¼ö mm¿¡¼­ Å« °ÍÀº 5cm·Î ±¸ÇüÀÇ Á¾±«À̸ç, °£È¤ ¿ÜÀڱà ±¸·Î µ¹ÃâÇϱ⵵ ÇÑ´Ù. Á¾±«´Â Ç¥¸éÀÌ ºÎµå·´°í Á¡¾×¼ºÀ̸ç, Çö¹Ì°æÀûÀ¸·Î Ç÷°ü¼º ¼¶À¯Á¡¾×¼º °£Áú Á¶Á÷³»¿¡ ³¶»óÀ¸·Î È®ÀåµÈ Á¡¾× ºÐºñ ÀÚ±Ã°æ ³»¸·¼±µéÀÌ °üÂûµÈ´Ù. µ¿½Ã¿¡ ±Ë¾çÀ̳ª ¸¸¼º ¿°ÁõÀÌ µ¿¹ÝµÇ¸ç, ÆíÆò »óÇÇ È­»ýÀ̳ª ½ÉÇÑ ¿°Áõ¼º »óÇÇ º¯È­¸¦ ÃÊ·¡ÇÒ ¼ö ÀÖ´Ù.
  • endometrial polyp
    Àڱ󻸷 Æú¸³
  • frontonasal polyp
    ÀüµÎµ¿¼º ºñ°­ Æú¸³
  • hamartomatous polyp
    °ú¿ÀÁ¾¼º Æú¸³
  • hydatid polyp
    Æ÷»ó Æú¸³
  • intestinal polyp
    Àå ¿ëÁ¾
    Æú¸³À̶õ ¼ÒÈ­°ü Á¡¸·¿¡¼­ µ¹ÃâÇÑ ¸ðµç Á¾·ùÀÇ À¶±â¸¦ °¡¸®Å²´Ù. Àå¿¡¼­´Â ¼ÒÀå¿¡ »ý±â´Â °ÍÀº ±ØÈ÷ Àû°í ´ëÀå¿¡ ¸¹´Ù. Á¶Á÷ÇÐÀûÀ¸·Î´Â ¾ÏÀ¸·Î µÇ´Â °æÇâÀ» °®´Â ¼±Á¾¼º Æú¸³°ú ±× ¿Ü¿¡ °ú¿ÀÁ¾¼º Æú¸³, ¿°Áõ¼º Æú¸³, È­»ý¼º Æú¸³ µîÀ¸·Î ³ª´¶´Ù.
  • mucous polyp
    Á¡¾×¼º Æú¸³
  • nasal polyp
    ºñ Æú¸³, ºñ ¿ëÁ¾
    µ¿ÀǾî=rhino
  • periodontal polyp
    Ä¡ÁÖ¸··ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
inflammatory polyp A projecting mass of granulation tissue, large numbers of which may develop in ulcerative colitis; may become covered by regenerating epithelium.
Synonym: inflammatory polyp.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acute inflammatory polyneuropathy <neurology, syndrome> Acute infective polyneuritis that results in a form of peripheral neuropathy with temporary loss of movement and sensation due to inflammation of multiple nerves and loss of myelin.
The exact cause is unknown but has been associated with an abnormal immune response to viral infection, particularly cytomegalovirus infection, in which there is cell-mediated immunity to a component of myelin. The disease may be autoimmune in origin and complete recovery can take up to six months.
Synonym: Guillain-Barre syndrome
(12 Jul 2000)
anti-inflammatory Counteracting or suppressing inflammation.
(18 Nov 1997)
anti-inflammatory agent Agents that counteract or suppress the inflammatory process. An antirheumatic agent or inflammation mediator, both endogenous and exogenous substances used to counteract the inflammatory process or alleviate or prevent rheumatic diseases, and the compounds that mediate the inflammation process.
(12 Dec 1998)
anti-inflammatory agent, non-steroidal Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain nsaids also may inhibit lipoxygenase enzymes or phospholipase c or may modulate T-cell function. (ama drug evaluations annual, 1994, p 1814-5)
(12 Dec 1998)
anti-inflammatory agent, steroidal Steroidal agents capable of suppressing or counteracting the inflammatory process by acting on body mechanisms, without directly antagonizing the causative agents.
(12 Dec 1998)
anti-inflammatory agent, topical Anti-inflammatory agent that are applied to the skin and whose pharmacological effect only occurs at the area of application.
(12 Dec 1998)
macrophage inflammatory protein <cytokine> A chemokine that is chemotactic for neutrophils and monocytes, stimulates macrophages, and may play a role in regulating haematopoiesis. Its two variants, mip-1alpha and mip-1beta, are 60% homologous to each other.
They are heparin-binding proteins that exhibit a number of inflammatory and immunoregulatory activities. Originally identified as secretory products of macrophages, these chemokines are produced by a variety of cell types including neutrophils, fibroblasts, and epithelial cells.
They most likely also play a significant role in respiratory tract defenses.
(20 Sep 2002)
pelvic inflammatory disease <disease> An inflammatory process that results from other pelvic diseases, may result from gonorrhoea, chlamydia, ovarian cystic disease or postpartum infections.
(27 Sep 1997)
chronic inflammatory demyelinating polyneuropathy An uncommon, acquired, demyelinating sensorimotor polyneuropathy, clinically characterised by insidious onset, and slow evolution, (either steady progression or stepwise), and chronic course; symmetrical weakness is a predominant symptom, often involving proximal leg muscles, accompanied by paresthesias, but not pain; CSF examination shows elevated protein, while electrodiagnostic studies reveal evidence of a demyelinating process, primarily conduction slowing rather than block; sometimes responds to prednisone.
(05 Mar 2000)
chronic inflammatory polyneuropathy <neurology, pathology> A disorder that involves the slow progressive (or recurrent) inflammation of multiple nerves. Loss of movement and sensation are common findings. The exact cause is related to an abnormal immune response.
The acute form of this illness is known as Guillain-Barre syndrome. Treatment often includes systemic corticosteroids or chemotherapeutic agents to suppress the immune system. Prognosis is variable.
Origin: Gr. Pathos = disease
(27 Sep 1997)
non-steroidal anti-inflammatory <pharmacology> A large group of anti-inflammatory agents that work by inhibiting the production of prostaglandins. They exert anti-inflammatory, analgesic and antipyretic actions.
Examples include: ibuprofen, ketoprofen, piroxicam, naproxen, sulindac, aspirin, choline subsalicylate, diflunisal, fenoprofen, indomethacin, meclofenamate, salsalate, tolmetin and magnesium salicylate.
A contrast is made with steroidal compounds (such as hydrocortisone or prednisone) exerting anti-inflammatory activity.
Acronym: NSAID
(05 May 2002)
non-steroidal anti-inflammatory drug <pharmacology> A large group of anti-inflammatory agents that work by inhibiting the production of prostaglandins. They exert anti-inflammatory, analgesic and antipyretic actions.
Examples include: ibuprofen, ketoprofen, piroxicam, naproxen, sulindac, aspirin, choline subsalicylate, diflunisal, fenoprofen, indomethacin, meclofenamate, salsalate, tolmetin and magnesium salicylate.
A contrast is made with steroidal compounds (such as hydrocortisone or prednisone) exerting anti-inflammatory activity.
Acronym: NSAID
(05 May 2002)
desquamative inflammatory vaginitis An acute inflammation of the vagina of unknown cause, characterised by grayish pseudomembrane, free discharge, and easy bleeding on trauma; the discharge contains pus and immature epithelial cells, although oestrogen levels are normal.
Vaginitis emphysematosa, vaginitis characterised by accumulation of gas in small connective tissue spaces lined by foreign-body giant cells.
Synonym: pachyvaginitis cystica, vaginitis cystica.
(05 Mar 2000)
disease, pelvic inflammatory Despite its seeming lack of gender, this term is applied to women only. PID refers exclusively to ascending infection of the female genital tract above the cervix.
(12 Dec 1998)
inflammatory <pathology> Inflammation is the reaction of living tissues to injury, infection or irritation. Inflamed tissues are characterised by pain, swelling, redness and heat. Anything that stimulates the inflammatory response is said to be inflammatory.
See: inflammation.
(11 Jun 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyp
    Æú¸³(»êÈ£ÀÇ ¹«¸®);½ÄÀ°;Æú¸³(ÄÚÀÇ Á¡¸· µûÀ§¿¡ »ý±â´Â ÁÙ±â ÀÖ´Â ¸»¶û¸»¶ûÇÑ Á¾±â)
  • inflammatory
    ¼±µ¿ÀûÀÎ
  • inflammatory
    ¿°ÁõÀ» ÀÏÀ¸Å°´Â;¿°Áõ¼ºÀÇ;°Ý¾Ó½ÃŰ´Â;¼±µ¿ÀûÀÎ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á